Mutations that alter RNA splicing of the human HPRT gene: A review of the spectrum

Mutation Research - Reviews in Mutation Research

Volumn 411, Issue 3, 1998, Pages 179-214

  O'Neill, J Patrick ^a   Rogan, Peter K ^b   Cariello, Neal ^c   Nicklas, Janice A ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Exon exlusion or exon skipping; HPRT; HPRT mutation; Human mutation; Splice site mutation

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; TIOGUANINE;

ALTERNATIVE RNA SPLICING; DNA SEQUENCE; DRUG RESISTANCE; EXON; GENE MUTATION; HUMAN; INTRON; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0032212402     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(98)00013-1     Document Type: Article

References (98)

1. Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65:1996;367-409.
2. Will C., Luhrmann R. Protein functions in pre-mRNA splicing. Curr. Opin. Cell Biol. 9:1997;320-328.
3. Reed R. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev. 6:1996;215-220.
4. Fu X.D. The superfamily of arginine/serine rich splicing factors. RNA. 1:1995;663-680.
5. Chiara M.D., Gozani O., Bennett M., Champion-Arnaud P., Palanfjian L., Reed R. Identification of proteins that interact with exon sequences, splice sites, and the branchpoint sequence during each stage of spliceosome assembly. Mol. Cell. Biol. 16:1996;3317-3326.
6. Dreyfuss G., Matunis M.J., PiZol-Roma S., Burd C.G. hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62:1993;289-321.
7. Fu X.-D. Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature. 365:1993;82-85.
8. Berget S.M. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:1995;2411-2414.
9. Sun J.-S., Manley J.L. A novel U2-U6 snRNA structure is necessary for mammalian mRNA splicing. Genes Dev. 9:1995;843-854.
10. Sontheimer E.J., Steitz J.A. The U5 and U6 small nuclear RNAs as active site components of the spliceosome. Science. 262:1993;1989-1991.
11. Crispino J.D., Blencowe B.J., Sharp P.A. Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science. 265:1994;1866-1869.
12. Tarn W.Y., Steitz J.A. Modulation of 5′ splice site choice in pre-messenger RNA by two distinct steps. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2504-2508.
13. Ca-ceres J.F., Stamm S., Helfman D.M., Krainer A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science. 265:1994;1706-1708.
14. Sun Q., Mayeda A., Hampson R.K., Krainer A.R., Rottman F.M. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:1993;2598-2608.
15. Singh R., Valcrcel J., Green M.R. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science. 268:1995;1173-1176.
16. Nakai K., Sakamoto H. Construction of a novel database containing aberrant mutations of mammalian genes. Gene. 141:1994;171-177.
17. Talerico M., Berget S.M. Effect of 5′ splice site mutations on splicing of the preceding intron. Mol. Cell. Biol. 10:1990;6299-6305.
18. Brunak S., Engelbrecht J., Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J. Mol. Biol. 220:1991;49-65.
19. Robberson B.L., Cote G.J., Berget S.M. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10:1990;84-94.
20. Wu J.Y., Maniatis T. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell. 75:1993;1061-1070.
21. Reed R., Maniatis T. A role for exon sequences and splice-site proximity in splice-site selection. Cell. 46:1986;681-690.
22. Watakabe A., Tanaka K., Shimura Y. The role of exon sequences in splice site selection. Genes Dev. 7:1993;407-418.
23. Xu R., Teng J., Cooper T.A. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:1993;3660-3674.
24. Laviguer A., La Branche H., Kornblihtt A.R., Chabot B. A splicing enhancer in the human fibronectin alternate exon ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:1993;2405-2417.
25. Hampson R.K., La Follette L., Rottman F.M. Alternative processing of bovine growth hormone mRNA is influenced by downstream exon sequences. Mol. Cell. Biol. 9:1989;1604-1610.
26. Huh G.S., Hynes R.O. Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes Dev. 8:1994;1561-1574.
27. Carlo T., Sterner D.A., Berget S.M. An intron splicing enhancer containing a G-rich repeat facilitates inclusion of a vertebrate micro-exon. RNA. 2:1996;342-353.
28. Del Gatto F., Gesnel M.-C., Breathnach R. The exon sequence TAGG can inhibit splicing. Nucl. Acids Res. 24:1996;2017-2021.
29. Furdon P.J., Kole R. The length of the downstream exon and the substitution of specific sequences affect pre-mRNA splicing in vitro. Mol. Cell. Biol. 8:1988;860-866.
30. Inoue K., Ohno M., Shimura Y. Aspects of splice site selection in constitutive and alternative pre-mRNA splicing. Gene Express. 4:1995;177-182.
31. Senapathy P., Shapiro M.B., Harris N.L. Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Meth. Enzymol. 183:1990;252-278.
32. Harris N.L., Senapathy P. Distribution and consensus of branch point signals in eukaryotic genes: a computerized statistical analysis. Nucl. Acids Res. 18:1990;3015-3019.
33. Penotti F.E. Human pre-mRNA splicing signals. J. Theor. Biol. 150:1991;385-420.
34. Schneider T.D. Sequence walkers: a graphical method to display how binding proteins interact with DNA or RNA sequences. Nucl. Acids Res. 25:1997;4408-4415.
35. Stephens R.M., Schneider T.D. Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J. Mol. Biol. 24:1992;1124-1136.
36. Shapiro M.B., Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucl. Acids Res. 15:1987;7155-7174.
37. Faux B.M., Schneider T.D., Rogan P.K. Information analysis of human splice site mutations. Am. J. Hum. Genet. 59:1996;A257.
38. Rogan P.K., Schneider T.D. Using information content and base frequencies to distinguish mutations from genetic polymorphisms in splice junction recognition sites. Hum. Mutat. 6:1995;74-76.
39. Rogan P.K., Faux B.M., Schneider T.D. Information analysis of human splice site mutations. Hum. Mut. 12:1998;153-171.
40. Roscigno R.F., Weiner M., Garcia-Blanco M.A. A mutational analysis of the polypyrimidine tract of introns. J. Biol. Chem. 268:1993;11222-11229.
41. Reed R. The organization of 3′ splice-site sequences in mammalian introns. Genes Dev. 3:1989;2113-2123.
42. Chu C.-S., Trapnell B.C., Curristin S., Cutting G.R., Crystal R.G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet. 3:1993;151-156.
43. Nelson K.K., Green M.R. Mammalian U2 snRNP has a sequence-specific RNA-binding activity. Genes Dev. 3:1989;1562-1571.
44. Reed R., Maniatis T. Intron sequences involved in lariat formation during pre-mRNA splicing. Cell. 41:1985;95-105.
45. Helfman D.M., Ricci W.M. Branch point selection in alternative splicing of tropomyosin pre-mRNAs. Nucl. Acids Res. 17:1989;5633-5650.
46. Estes P.A., Cooke N.E., Liebhaber S.A. A native RNA secondary structure controls alternative splice-site selection and generates two human growth hormone isoforms. J. Biol. Chem. 267:1992;14902-14908.
47. Cooper T.A. In vitro splicing of cardiac troponin precursors. J. Biol. Chem. 267:1992;5330-5338.
48. Libri D., Goux-Pelletan M., Brody E., Fiszman M.Y. Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the α tropomyosin gene. Mol. Cell. Biol. 10:1990;5036-5046.
49. Smith C.W.J., Nadal-Ginard B. Mutually exclusive splicing of α-tropomyosin exons enforced by an unusual lariat branch point location: implications for constitutive splicing. Cell. 56:1989;749-758.
50. Carothers A.M., Urlaub G., Grunberger D., Chasin L.A. Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol. Cell. Biol. 13:1993;5085-5098.
51. Smith W.J.T., Chu C.T., Nadal-Ginard B. Scanning and competition between AGs are involved in 3′ splice site selection in mammalian introns. Mol. Cell. Biol. 13:1993;4939-4952.
52. Ruskin B., Greene J.M., Green M.R. Cryptic branch point activation allows accurate in vitro splicing of human $-globin intron mutants. Cell. 41:1985;833-844.
53. Dominiski Z., Kole R. Selection of splice sites in pre-mRNAs with short internal exons. Mol. Cell. Biol. 11:1991;6075-6083.
54. Liu X., Mertz J.E. Sequence of the polypyrimidine tract of the 3′-terminal 3′ splicing signal can affect intron-dependent pre-mRNA processing in vivo. Nucl. Acids Res. 24:1996;1765-1773.
55. Izaurraide E., Lewis J., McGuigan C., Jankowska M., Darzynkiewicz E., Mattaj I.W. A nuclear cap binding protein complex involved in pre-mRNA splicing. Cell. 78:1994;657-668.
56. Niwa M., Rose S.D., Berget S.M. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 4:1990;1552-1559.
57. Wieringa B., Hofer E., Weissman C. A minimal intron length but no specific internal sequence is required for splicing the large rabbit $-globin intron. Cell. 37:1984;915-925.
58. Bateman J.F., Chan D., Moeller I., Hannagan M., Cole W.G. A 5′ splice site mutation affecting the pre-mRNA splicing of two upstream exons in the collagen COL 1A1 gene. Biochem. J. 302:1994;729-735.
59. Sterner D.A., Berget S.M. In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol. Cell. Biol. 13:1993;2677-2687.
60. Ge H., Noble J., Colgan J., Manley J.L. Polyoma virus small tumor antigen pre-mRNA splicing requires cooperation between two 3′ splice sites. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3338-3342.
61. Aoshima M., Nunoi H., Shimazu M., Shimizu S., Tatsuzawa O., Kenney R.T., Kanegasaki S. Two-exon skipping due to a point mutation in p67-phox-deficient chronic granulomatous disease. Blood. 88:1996;1841-1845.
62. Ligtenberg M.J.L., Gennissen A.M.C., Vos H.L., Hilkens J. A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA. Nucl. Acids Res. 19:1991;297-304.
63. Krawczak M., Reiss J., Cooper D.N. The mutational spectrum of single base-pair substitutions in the mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 90:1992;41-54.
64. Dietz H.C., Valle D., Francomano C.A., Kendzior R.J. Jr., Pyeritz R.E., Cutting G.R. The skipping of constitutive exons in vivo induced by nonsense mutations. Science. 259:1993;680-683.
65. Urlaub G., Mitchell P.J., Ciudad C.J., Chasin L.A. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol. Cell. Biol. 9:1989;2868-2880.
66. Weil D., D'Alessio M., Ramirez F., de Wet W., Cole W.G., Chan D., Bateman J.F. A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome Type VII. EMBO J. 8:1989;1705-1710.
67. Fisher C.W., Fisher C.R., Chuang J.L., Lau K.S., Chuang D.T., Cox R.P. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations. Am. J. Hum. Genet. 52:1993;414-424.
68. Ricketts M.H., Simons M.J., Parma J., Mercken L., Dong Q., Vassart G. A nonsense mutation causes hereditary goitre in the Afrikaner cattle and unmasks alternative splicing of thyroglobulin transcripts. Proc. Natl. Acad. Sci. U.S.A. 84:1987;3181-3184.
69. Smooker P.M., Christodoulou J., McInnes R.R., Cotton R.G.H. A mutation causing DHPR deficiency results in a frameshift and a secondary splicing defect. J. Med. Genet. 32:1995;220-223.
70. Aoufouchi S., Yjlamos J., Milstein C. Nonsense mutations inhibit RNA splicing in a cell-free system: recognition of mutant codon is independent of protein synthesis. Cell. 85:1996;415-422.
71. Santisteban I., Arredondo-Vega F.X., Kelly S., Loubser M., Meydan N., Roifman C., Howell P.L., Bowen T., Weinberg K.I., Schroeder M.L., Hershfield M.S. Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum. Mol. Genet. 4:1995;2081-2087.
72. Pulak R., Anderson P. mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev. 7:1993;1885-1897.
73. Maquat L.E. Defects in RNA splicing and the consequence of shortened translational reading frames. Am. J. Hum. Genet. 59:1996;279-286.
74. Edwards A., Voss H., Rice P., Civitello A., Stegemann J., Schwager C., Zimmerman J., Erfle H., Caskey C.T., Ansorge W. Automated DNA sequencing of the human HPRT locus. Genomics. 6:1990;593-608.
75. Nicklas J.A., Hunter T.C., O'Neill J.P., Albertini R.J. Fine structure mapping of the hprt gene region of the human X chromosome (Xq26). Am. J. Hum. Genet. 49:1990;267-278.
76. Cariello N.F., Craft T.R., Vrieling H., van Zeeland A.A., Adams T., Skopek T.R. Human HPRT mutant database: software for data entry and retrieval. Environ. Mol. Mutagenesis. 20:1992;81-83.
77. Fuscoe J.C., Zimmerman L.J., Lippert M.L., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res. 51:1991;6001-6005.
78. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Burnette L., Moore M.M., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutation Res. 283:1992;13-20.
79. Steingrimsdottir H., Rowley G., Dorado G., Cole J., Lehmann A.R. Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucl. Acids Res. 20:1992;1201-1208.
80. - mutations in TK6 human lymphoblasts. Environ. Mol. Mutagenesis. 22:1993;138-146.
81. Guillouf C., Laquerbe A., Moustacchi E., Papadopoulo D. Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells. Mutagenesis. 8:1993;355-361.
82. Yamada Y., Goto H., Suzumori K., Ritsuko A., Ogasawara N. Molecular analysis of five independent Japanese mutant genes responsible for hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency. Hum. Genet. 90:1992;379-384.
83. Nelson S., Giver C.R., Grosovshy A.J. Spectrum of X-ray-induced mutations in the human hprt gene. Carcinogenesis. 15:1994;495-502.
84. Marcus S., Hellgren D., Lambert B., Fällström S.P., Wahlström J. Duplication in the hypoxanthine phosphoribosyl-transferase gene caused by Alu-Alu recombination in a patient with Lesch-Nyhan syndrome. Hum. Genet. 90:1993;477-482.
85. Yang S., Lin J.G., Chiou C.C., Chen L.Y., Yang J.L. Mutation specificity of 8-methoxypsoralen plus two doses of UVA irradiation in the hprt gene in diploid human fibroblasts. Carcinogenesis. 15:1994;201-207.
86. Bastlova T., Andersson B., Lambert B., Kilman A. Molecular analysis of ethylene oxide induced mutations at the hprt locus in human diploid fibroblasts. Mutation Res. 287:1993;283-292.
87. Rossi A.M., Tates A.D., van Zeeland A.A., Vrieling H. Molecular Analysis of Mutations Affecting hprt mRNA Splicing in Human T-lymphocytes in vivo. Environ. Mol. Mutagenesis. 19:1992;7-13.
88. Lichtenauer-Kaligis E.G.R., Thijssen J.C.P., den Dulk H., van de Putte P., Giphart-Gassler M., Tasseron-de Jong J.G. Spontaneous mutation spectrum in the hprt gene in human lyphoblastoid TK6 cells. Mutagenesis. 10:1995;137-143.
89. Sege-Peterson L., Chambers J., Page T., Jones O.W., Nyhan W.L. Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency. Hum. Mol. Genet. 1:1992;427-442.
90. Lippert M.J., Rainville I.R., Nicklas J.A., Albertini R.J. Large deletions partially external to the human hprt gene result in chimeric transcripts. Mutagenesis. 12:1997;185-190.
91. Cleary M.L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell. 66:1991;619-622.
92. Manjanatha M.G., Lindsey L.A., Mittelstaedt R.A., Heflich R.H. Low hprt mRNA levels and multiple hprt mRNA species in 6-thioguanine-resistant Chinese hamster cell mutants possessing nonsense mutations. Mutation Res. 308:1994;65-75.
93. Valentine C.R., Heflich R.H. The association of nonsense mutation with exon-skipping in hprt mRNA of Chinese hamster ovary cells results from an artifact of RT-PCR. RNA. 3:1997;660-676.
94. Valentine, C.R. (in press), Origin of exon-deleted mRNAs associated with nonsense mutations, Mutation Research.
95. Menichini P., Inga A., Fronza G., Iannone R., Degan P., Campomenosi P., Abbondandolo A. Defective splicing induced by 4NQO in the hamster hprt gene. Mutation Res. 323:1994;159-165.
96. Hennig E.E., Conney A.H., Wei S.-J.C. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese Hamster V-79 cells. Cancer Res. 55:1995;1550-1558.
97. Zhang L.-H., Vrieling H., van Zeeland A.A., Jenssen D. Spectrum of spontaneously occurring mutations in the hprt gene of V79 Chinese hamster cells. J. Mol. Biol. 223:1992;627-635.
98. Valentine C.R., Heflich R.H. Genomic DNA sequencing of mRNA splicing mutants in the hprt gene of Chinese Hamster ovary cells. Environ. Mol. Mutagenesis. 25:1995;85-96.